A pregnant woman presents in labor at term, having had no prenatal care. After birth, her infant is noted to be small for gestational age with small eyes and a thin upper lip. The infant also is microcephalic. On the basis of her infant's physical findings, this woman should be asked about her use of which substance during pregnancy?

Choice A rationale Maternal marijuana use is not typically associated with the classic constellation of physical features described (small for gestational age, small eyes, thin upper lip, microcephaly). While it can potentially affect fetal growth and neurodevelopment, the specific pattern of dysmorphic facial features and microcephaly strongly points to a distinct syndrome. Choice B rationale Heroin (an opioid) use during pregnancy is associated with neonatal abstinence syndrome (NAS), characterized by central nervous system hyperirritability and autonomic dysfunction post-birth. While growth restriction can occur, the characteristic craniofacial anomalies (small eyes, thin upper lip, microcephaly) are not the primary features of in utero opioid exposure. Choice C rationale Cocaine use during pregnancy can lead to vasoconstriction and placental insufficiency, resulting in fetal growth restriction (SGA) and potential central nervous system damage (microcephaly). However, the specific pattern of distinctive facial anomalies described is not the hallmark of cocaine embryopathy. Choice D rationale Maternal alcohol consumption, particularly heavy intake, can cause Fetal Alcohol Syndrome (FAS). The physical findings described—small for gestational age, microcephaly, short palpebral fissures (small eyes), and an indistinct or thin upper lip—are the classic diagnostic triad for FAS, resulting from alcohol's teratogenic effects on cell migration and development.